Latest News - Pixium Vision

Thursday, October 19, 2017 | Acquisitions/Mergers, Blindness, AMD, Pixium Vision

Pixium Vision Receives Approval for First-in-Human Clinical Trial of PRIMA, Its Miniaturized Sub-Retinal Implant

Pixium Vision announced that its next-generation miniaturized wireless subretinal implant, PRIMA, aimed at restoring vision in patients affected by retinal dystrophies, received authorization from the…

Read the full story

Wednesday, September 27, 2017 | Blindness, Pixium Vision

Pixium Vision Announces Updates on its Epi-Retinal IRIS II Bionic Vision System

Pixium Vision, which is developing bionic vision systems to enable patients who have lost their sight to lead more independent lives, announced updates on its epi-retinal IRIS II system, CE marked for…

Read the full story

Wednesday, May 03, 2017 | Conferences, Pixium Vision

Pixium Vision and Research Partners Report Progress in Multiple Areas with IRIS and PRIMA during ARVO 2017

Pixium Vision announced its scientific program with multiple presentations of clinical and preclinical results at the Association for Research in Vision and Ophthalmology (ARVO) 2017 world congress in…

Read the full story

Friday, February 17, 2017 | Clinical Trials, Product Releases, Pixium Vision

Pixium Vision Announces First Implantation and Activation of IRIS II in Spain

Pixium Vision announced the first implantation and activation of IRIS II in Spain. This implantation is part of Pixium Vision’s ongoing multicenter clinical trial to assess the performance of IR…

Read the full story

Tuesday, February 14, 2017 | Earnings & Financials, Retina, Pixium Vision

Pixium Vision Receives NUB Innovation Reimbursement Status-1 for 150 Electrode IRIS II Bionic System in Germany

Pixium Vision announced that the German Institute for the Hospital Remuneration System (InEK) has granted NUB (Neue Untersuchungs- und Behandlungsmethoden) Status-1 for IRIS II, Pixium Vision’s …

Read the full story

Friday, January 13, 2017 | Clinical Trials, Pixium Vision

Pixium Vision Achieves Implantation of 10 Patients in Its Clinical Trial with Its Innovative 150 Electrodes IRIS II Bionic Vision System

Pixium Vision announced the completion of 10 implants in its IRIS II study. All implanted patients will now follow their reeducation program as defined in the ongoing European multicentric study for I…

Read the full story

Tuesday, November 08, 2016 | Blindness, Pixium Vision

Pixium Vision Announces the First Successful Implantation and Activation of IRIS II, 150 Electrode Bionic Vision System, in the UK

Pixium Vision announced the first successful implantation and activation of IRIS II in the UK. This epiretinal implant with 150 electrodes is intended for patients who have lost sight as a result of r…

Read the full story

Monday, August 01, 2016 | CE Mark Approval, Pixium Vision

Pixium Vision Receives CE Mark Approval of IRIS II Bionic Vision System

Pixium Vision announced that it has been awarded the CE mark for its IRIS II bionic vision system, indicated for people with vision loss from outer retinal degeneration. The 150-electrode epiretinal i…

Read the full story

Tuesday, May 31, 2016 | Clinical Trials, Pixium Vision

Pixium Vision Receives Clinical Trial Approval From UK Regulatory Authority for 150 Electrode IRIS II Bionic Vision System

Pixium Vision announced that it has received approval from the Medicines & Healthcare products Regulatory Agency (MHRA) in the UK to initiate a clinical trial for patients who have lost sight due …

Read the full story